Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-005167

PORTOLA PHARMACEUTICALS INC · PTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
William Lis
Officer — Chief Executive Officer · Director
Period of report
Jan 20, 2015
Accepted (ET)
Jan 20, 2015 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 20, 2015M20,000$5.10A20,000D
Common StockF2,F1Jan 20, 2015S19,800$27.317D200D
Common StockF3,F1Jan 20, 2015S200$27.808D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$5.10Jan 20, 2015M6,131DFeb 25, 2009Feb 25, 2019Common Stock6,1310D
Stock Option (Right to Buy)F1$5.10Jan 20, 2015M13,869DFeb 25, 2009Feb 25, 2019Common Stock13,8691,593D

Explanation of responses